reveromycin A,
Reveromycin A,
134615-37-5,
AC1O5RK5,
SCHEMBL14012106,
MFCD00912537,
J-006566,
(2E,6E,8E)-10-(9-butyl-8-((1E,3E)-4-carboxy-3-methylbuta-1,3-dienyl)-9-(3-carboxypropanoyloxy)-3-methyl-1,7-dioxaspiro[5.5]undecan-2-yl)-5-hydroxy-4,8-dimethyldeca-2,6,8-trienoic acid,
(2E,6E,8E)-10-[9-butyl-10-[(1E,3E)-5-hydroxy-3-methyl-5-oxopenta-1,3-dienyl]-9-(4-hydroxy-4-oxobutanoyl)oxy-3-methyl-5,11-dioxaspiro[5.5]undecan-4-yl]-5-hydroxy-4,8-dimethyldeca-2,6,8-trienoic acid,
5-Hydroxy-4,8-dimethyl-10-[9-butyl-3-methyl-8-(4-carboxy-3-methyl-1,3-butadienyl)-9-(4-hydroxy-1,4-dioxobutoxy)-1,7-dioxaspiro[5.5]undecan-2-yl]-2,6,8-decatrienoic acid,
REVEROMYCINA,
C36H52O11,
CID6439382,
C36-H52-O11,
Mono(3-butyl-8-(9-carboxy-6-hydroxy-3,7-dimethyl-2,4,8-nonatrienyl)-2-(4-carboxy-3-methyl-1,3-butadienyl)-9-methyl-1,7-dioxaspiro(5.5)undec-3-yl) butanedioate,